[Skip to Content]
[Skip to Content Landing]
Citations 0
Health Agencies Update
December 22/29, 2004

Alzheimer Study to Recruit Patients

JAMA. 2004;292(24):2963. doi:10.1001/jama.292.24.2963-a

The National Institute on Aging, in Bethesda, Md, is joining other federal agencies and some pharmaceutical companies to conduct a $60 million effort to study Alzheimer disease. The Alzheimer’s Disease Neuroimaging Initiative will track changes in the brains of 800 participants aged 55 to 90 years. The study will include 200 individuals with normal cognition, 400 with mild cognitive impairment, and 200 with early-stage Alzheimer disease.

The goal is to test whether serial magnetic resonance imaging, positron emission tomography, and clinical and neuropsychological assessment can be combined to measure the progression of mild cognitive impairment and early Alzheimer disease. The study could help researchers develop new treatments and monitor the effectiveness of therapies during clinical trials.

First Page Preview View Large
First page PDF preview
First page PDF preview